Mankind Pharma IPO shares trade with single-digit premium in grey market
Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.
Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22. Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22. Moneycontrol Latest News Read More
Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.